ketoprofen
Generic: KETOPROFEN·Brand: ACTRON, KETOPROFEN, NEXCEDE, ORUDIS, ORUDIS KT, ORUVAIL
ketoprofen: developed by 1 company · 1 clinical trial tracked · 1 FDA decision.
ketoprofen evidence translation
What we can confirm
1 FDA record · 1 tracked trial
What it means
Source-backed records connect ketoprofen to NVS; that link alone does not prove the drug works.
What to watch
Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected
Prepared research question
How could ketoprofen → NVS affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
Development Pipeline (2)
| Company | Phase |
|---|---|
| Novartis AG (NVS) | Approved |
| Novartis AG (NVS) | Approved |
Clinical Trials (1)
Paracetamol With or Without Ketoprofen in the Management of Pain During Hospitalisation and at Home for Patients Receiving Brachytherapy: Phase-2 Randomized Study
Primary endpoint: Level of immediate post-operative pain
InterventionalRandomizedopen68 enrolledStarted 2015-02Completion 2016-101 site · FranceCentre Oscar Lambret
Frequently asked questions
Who is developing ketoprofen?
ketoprofen is being developed by Novartis AG.
How many clinical trials involve ketoprofen?
BioSniper tracks 1 clinical trial involving ketoprofen.
What is ketoprofen's latest FDA decision?
The most recent tracked FDA decision for ketoprofen is Approval, dated November 25, 2009.